Related Experiment Video

Updated: May 24, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Circulating MicroRNA as Biomarkers: An Update in Prostate Cancer

Anvesha Srivastava1, Simeng Suy, Sean P Collins

  • 1Cancer Research Laboratory, Department of Biology, University of the District of Columbia, Washington, DC.

Molecular and Cellular Pharmacology
|March 2, 2012
PubMed

Insights

Prostate cancer diagnosis can be improved using circulating microRNAs (miRNAs). These stable molecules found in body fluids offer a promising, more accurate biomarker for early cancer detection and potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Prostate cancer (PCa) is a prevalent cancer in men, but current diagnostic methods lack sufficient specificity and sensitivity.
  • Existing diagnostic tools for PCa are inadequate, necessitating the development of improved biomarkers.
  • MicroRNAs (miRNAs) present a potential solution due to their cancer-specific expression and stability.

Purpose of the Study:

  • To review the potential of circulating miRNAs as diagnostic and therapeutic agents for prostate cancer.
  • To summarize the current research on circulating miRNAs in the context of PCa.
  • To highlight miRNAs as promising biomarkers for improved cancer detection and treatment.

Main Methods:

  • Literature review focusing on circulating miRNAs in prostate cancer.
  • Analysis of miRNA stability, detectability, and quantification in biological samples.
  • Evaluation of miRNAs as molecular markers for cancer detection and therapeutic targets.

Main Results:

  • Circulating miRNAs are stable and detectable in various body fluids, including serum and plasma.
  • miRNAs show promise as sensitive and specific biomarkers for prostate cancer.
  • These molecules can be quantified in both fresh and preserved tissue samples.

Conclusions:

  • Circulating miRNAs represent a significant advancement in molecular diagnostics for cancer.
  • They hold potential for revolutionizing prostate cancer diagnosis and therapeutics.
  • Further investigation into circulating miRNAs is crucial for clinical applications in oncology.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...